Transparent Monthly Pricing
Better Pricing
Without the Commitment
Get started with provider-guided treatment without memberships, contracts, or surprise price increases.
GET STARTED NOW →- No Membership Fees
- No Long-Term Commitment
- Same Price Across All Doses
Explore Our Treatments
Weight Loss
Provider-supervised compounded GLP-1 medications, shipped discreetly to your door.
Learn More →
Longevity
Compounded NAD+ and longevity-focused therapies. New treatments coming soon.
Coming Soon
Three Easy Steps
Choose Your Treatment & Complete Medical Intake
Provider Reviews Your Responses for Eligibility
If Approved, Medications Shipped Directly to You
Treatment
Weight Loss
Compounded GLP-1 medications prescribed by licensed providers when clinically appropriate.
Weekly Injectable
Compounded Semaglutide
$447 every 3 months · auto-renews until you cancel
Same Price, Even as Your Dose Changes
Weekly Injectable
Compounded Tirzepatide
$597 every 3 months · auto-renews until you cancel
Same Price, Even as Your Dose Changes
Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required after a provider evaluation. Not available in all states. Billing frequency, total cost, and cancellation terms are shown before checkout. Individual results vary.
Treatment
Longevity
Compounded longevity therapies to support healthy aging. Coming soon.
Compounded NAD+
Frequently Asked Questions
Compounded medications are prepared by state-licensed compounding pharmacies under applicable USP compounding standards. They are not FDA-approved and have not been reviewed by the FDA for safety or effectiveness. Whether a compounded medication is appropriate for you is decided by a licensed provider.
Important Safety Information
Compounded semaglutide and tirzepatide are GLP-1 medications that may cause side effects, including nausea, vomiting, diarrhea, constipation, and other gastrointestinal symptoms; serious risks may include pancreatitis and gallbladder problems. GLP-1 medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Not for use during pregnancy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. Talk to a licensed provider about whether treatment is right for you. Individual results vary.